We are live on ! Find out more
RXRX icon

Recursion Pharmaceuticals
RXRX

75 hedge funds and large institutions have $1.71B invested in Recursion Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 75 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

27.91% more ownership

Funds ownership: 0% → 27.91% (+28%)

Holders
75
Holders Change
+75
Holders Change %
–
% of All Funds
1.31%
Holding in Top 10
6
Holding in Top 10 Change
+6
Holding in Top 10 Change %
% of All Funds
0.1%
New
75
Increased
–
Reduced
–
Closed
–
Calls
$705K
Puts
–
Net Calls
+$705K
Net Calls Change
+$705K

Top Buyers

1
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$548M
2
LCM
Laurion Capital Management
New York
+$114M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$79.4M
4
AIM
ARK Investment Management
Florida
+$70.4M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$65.5M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
NAMA
26
Nikko Asset Management Americas
New York
$8.61M +$6.98M +235,846 New
Sumitomo Mitsui Trust Group
27
Sumitomo Mitsui Trust Group
Japan
$7.8M +$6.32M +213,608 New
AG
28
Artal Group
Luxembourg
$7.3M +$5.92M +200,000 New
Charles Schwab
29
Charles Schwab
California
$6.02M +$4.88M +164,881 New
RCM
30
Ratan Capital Management
Florida
$4.01M +$3.26M +110,000 New
HI
31
HBK Investments
Texas
$3.65M +$2.96M +100,000 New
TRSOTSOK
32
Teachers Retirement System of the State of Kentucky
Kentucky
$3.09M +$2.51M +84,776 New
N
33
Nuveen
North Carolina
$2.87M +$2.33M +78,730 New
Bank of New York Mellon
34
Bank of New York Mellon
New York
$2.68M +$2.17M +73,394 New
AO
35
Allen Operations
New York
$2.49M +$2.02M +68,104 New
Susquehanna International Group
36
Susquehanna International Group
Pennsylvania
$1.85M +$1.5M +50,646 New
TD Asset Management
37
TD Asset Management
Ontario, Canada
$1.23M +$1.2M +40,634 New
Russell Investments Group
38
Russell Investments Group
United Kingdom
$1.15M +$933K +31,533 New
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$1.06M +$863K +29,154 New
State of Wisconsin Investment Board
40
State of Wisconsin Investment Board
Wisconsin
$996K +$808K +27,300 New
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$760K +$616K +20,818 New
JP Morgan Chase
42
JP Morgan Chase
New York
$730K +$592K +19,992 New
BG
43
Bellevue Group
Switzerland
$730K +$592K +20,000 New
New York State Common Retirement Fund
44
New York State Common Retirement Fund
New York
$661K +$536K +18,100 New
CCM
45
CAAS Capital Management
New York
$548K +$444K +15,000 New
Manulife (Manufacturers Life Insurance)
46
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$520K +$421K +14,240 New
CSS
47
Cubist Systematic Strategies
Connecticut
$496K +$403K +13,600 New
CF
48
CNA Financial
Illinois
$490K +$398K +13,432 New
Deutsche Bank
49
Deutsche Bank
Germany
$479K +$388K +13,122 New
Goldman Sachs
50
Goldman Sachs
New York
$402K +$326K +11,013 New
1
2
3

RXRX Hedge Fund Activity: Q2 2021 in Review

75 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Recursion Pharmaceuticals (RXRX) for Q2 2021, worth a combined $1.71B.

Buyers outnumbered sellers: 75 funds opened new RXRX positions and 0 closed out — a net gain of 75 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Baillie Gifford & Co, opening a new position worth an estimated $548M.

  • 75 institutional investors held Recursion Pharmaceuticals (RXRX) as of Q2 2021, up from 0 in Q1 2021.
  • Funds reported $1.71B of Recursion Pharmaceuticals stock for Q2 2021.
  • 75 funds opened new Recursion Pharmaceuticals positions in Q2 2021 and 0 closed out, a net change of +75 holders.
  • The largest Recursion Pharmaceuticals buyer in Q2 2021 was Baillie Gifford & Co, an estimated $548M added.

Based on aggregated 13F filings for Q2 2021.